subscribeSubscribe
Apotex`s Generic Nilotinib Hydrochloride Receives Approval in the U.S.

Apotex`s Generic Nilotinib Hydrochloride Receives Approval in the U.S.
FDA
05 Jan 2024
Share Share
Eugia signs voluntary license with Medicines Patent Pool to develop Nilotinib

Eugia signs voluntary license with Medicines Patent Pool to develop Nilotinib
INDIANPHARMAPOST
23 Jun 2023
Share Share
Aurobindo arm signs pact with Medicines Patent Pool to develop anti-cancer drug

Aurobindo arm signs pact with Medicines Patent Pool to develop anti-cancer drug
ECONOMIC TIMES
23 Jun 2023
Share Share
Novartis will let generic Tasigna to be provided to poor nations

Novartis will let generic Tasigna to be provided to poor nations
Kevin Dunleavy FIERCE PHARMA
23 Jun 2023
Share Share
MPP signs on four generics makers to make Novartis` Tasigna more accessible

MPP signs on four generics makers to make Novartis` Tasigna more accessible
Paul Schloesser ENDPTS
22 Jun 2023
Share Share
Novartis Pharma Signs World`s 1st Licensing Deal For Cancer Drug

Novartis Pharma Signs World`s 1st Licensing Deal For Cancer Drug
NDTV
21 Oct 2022
Share Share
Novartis signs landmark licensing deal to expand access to patented cancer drug

Novartis signs landmark licensing deal to expand access to patented cancer drug
Zachary Brennan ENDPTS
20 Oct 2022
Share Share
Apotex`s Generic Nilotinib Hydrochloride Receives Tentative Approval in the U.S.

Apotex`s Generic Nilotinib Hydrochloride Receives Tentative Approval in the U.S.
FDA
10 Jun 2022
Share Share
Novartis Blocks Sun’s Nilotinib Plans In India

Novartis Blocks Sun’s Nilotinib Plans In India
Anju Ghangurde INFORMA
29 Sep 2020
Share Share
Leukaemia drug nilotinib shows promise against Alzheimer’s clinical study

Leukaemia drug nilotinib shows promise against Alzheimer’s clinical study
PHARMAFILE
29 May 2020
Share Share